Cleared Traditional

K822799 - STREPTACOCCUS CO-AGGLUTINATION KIT

K822799 is an FDA 510(k) clearance for STREPTACOCCUS CO-AGGLUTINATION KIT, manufactured by American Scientific Products. The device is a Class 1 Microbiology device with product code GTP cleared through the Traditional 510(k) pathway after a 94-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1982
Decision
94d
Days
Class 1
Risk

K822799 is an FDA 510(k) clearance for the STREPTACOCCUS CO-AGGLUTINATION KIT. Classified as Exoenzymes, Multiple, Streptococcal (product code GTP), Class I - General Controls.

Submitted by American Scientific Products (Walker, US). The FDA issued a Cleared decision on December 19, 1982 after a review of 94 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3720 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all American Scientific Products devices

FDA 510(k) Submission Details - K822799

510(k) Number K822799 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 1982
Decision Date December 19, 1982
Days to Decision 94 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d faster than avg
Panel avg: 102d · This submission: 94d
Pathway characteristics
Predicate-based equivalence.

GTP Device Classification - Class 1, General Controls

Product Code GTP Exoenzymes, Multiple, Streptococcal
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3720
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.